North Asia-focused buyout firm MBK Partners has sold a 12% GP stake to Dyal Capital Partners, a unit of US-based alternative investment firm Blue Owl that buys interests in third-party managers.
The development was first reported by Bloomberg and has since been confirmed to AVCJ by a source close to the situation. While Bloomberg claimed that Dyal had acquired “roughly 13%” of MBK’s management...
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has closed a Series C extension led by SummitView Capital. This brings the size of the overall round to USD 500m.
Japanese lower middle-market private equity firm J-Star has made an investment of undisclosed size in air cargo transportation and courier services provider Score Japan Holdings.
Gaorong Capital and Tsing Song Capital have led a CNY 500m (USD 74m) Series C for IntellectiveBio, a China-based contract development and manufacturing organisation (CDMO).
Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.